Researcher seeks TB biomarker ML collaborators

This is an early-stage collaboration call, not a product launch, but it is a legitimate applied-ML research signal in biomedical diagnostics.

• –Focus is on peak detection quality and pipeline correctness, which are core bottlenecks in mass-spec ML workflows.
• –The request suggests labeled biomarker knowledge already exists, so model validation and feature engineering likely matter more than model novelty.
• –Low engagement so far (score/comments) implies limited traction yet, but strong upside if converted into a reproducible research artifact.